Neuropsychiatric adverse drug reactions induced by montelukast impair the quality of life in children with asthma

Bayer O. Y., Türktaş İ., Karagol H. İ., Soysal S., Yapar D.

JOURNAL OF ASTHMA, cilt.59, sa.3, ss.580-589, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 59 Sayı: 3
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1080/02770903.2020.1861626
  • Dergi Adı: JOURNAL OF ASTHMA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Psycinfo, Veterinary Science Database
  • Sayfa Sayıları: ss.580-589
  • Anahtar Kelimeler: Quality of Life, treatment, pediatrics, pharmacotherapy
  • Gazi Üniversitesi Adresli: Evet

Özet

Introduction: Montelukast-induced neuropsychiatric adverse drug reactions (ADRs) have been reported in retrospective studies. This study aimed to reveal the neuropsychiatric ADRs triggered in patients taking montelukast due to asthma in real time, and to evaluate the effect of these ADRs on quality of life (QoL).